Abstract
Short interfering RNAs, or siRNAs, belong to a class of RNA species which play a role in both cellular defence and gene regulation. siRNAs are members of a larger RNA interference pathway found within cells and are involved in the degradation of RNAs which possess complementarity to specific target sequences. This property has given siRNA technology the potential to become a powerful new tool for a wide variety of disciplines, ranging from the design of novel anti-cancer agents to agricultural applications. The following review outlines novel delivery systems that can be used for applied siRNA technologies. Improved delivery systems for the cellular uptake of siRNAs using both viral expression vectors and nanoliposomal particles are discussed. New therapeutics that can be used to combat human disease and agricultural applications of siRNA technologies are also described. This review attempts to pave the way for future innovations based upon RNA interference in medicine and agriculture.
Keywords: siRNA, nanocarrier, lentiviral vector, delivery vehicle, RNA interference, siRNA Conjugates, virus expression vectors, Nonviral Nanocarrier Systems, VEGFR, neurodegenerative diseases
Drug Delivery Letters
Title: Delivery Systems for Applications in siRNA Technology
Volume: 1 Issue: 2
Author(s): Kathleen L. Hefferon
Affiliation:
Keywords: siRNA, nanocarrier, lentiviral vector, delivery vehicle, RNA interference, siRNA Conjugates, virus expression vectors, Nonviral Nanocarrier Systems, VEGFR, neurodegenerative diseases
Abstract: Short interfering RNAs, or siRNAs, belong to a class of RNA species which play a role in both cellular defence and gene regulation. siRNAs are members of a larger RNA interference pathway found within cells and are involved in the degradation of RNAs which possess complementarity to specific target sequences. This property has given siRNA technology the potential to become a powerful new tool for a wide variety of disciplines, ranging from the design of novel anti-cancer agents to agricultural applications. The following review outlines novel delivery systems that can be used for applied siRNA technologies. Improved delivery systems for the cellular uptake of siRNAs using both viral expression vectors and nanoliposomal particles are discussed. New therapeutics that can be used to combat human disease and agricultural applications of siRNA technologies are also described. This review attempts to pave the way for future innovations based upon RNA interference in medicine and agriculture.
Export Options
About this article
Cite this article as:
L. Hefferon Kathleen, Delivery Systems for Applications in siRNA Technology, Drug Delivery Letters 2011; 1 (2) . https://dx.doi.org/10.2174/2210304x11101020118
DOI https://dx.doi.org/10.2174/2210304x11101020118 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
Call for Papers in Thematic Issues
Nanomaterial Assisted Targeted Therapies for Chronic Disorders- Preclinical to Clinical Outcomes
In recent years, the integration of nanomaterials into therapeutic strategies has emerged as a promising avenue in the pursuit of more effective treatments for chronic disorders. This dynamic field, explored in the context of "Nanomaterial Assisted Targeted Therapies for Chronic Disorders - Preclinical to Clinical Outcomes," seeks to bridge the ...read more
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
subject Index To Volume 1
Current Drug Targets - Infectious Disorders Coumarins as Inhibitors of HIV Reverse Transcriptase
Current HIV Research Brain Targeted Drug Delivery: Factors, Approaches and Patents
Recent Patents on Nanomedicine Gene Cloning and Homology Modeling of the 3-Oxoacyl-ACP Synthase from Aeromonas hydrophila for Drug Discovery
Letters in Drug Design & Discovery Dengue Virus RNA Polymerase NS5: A Potential Therapeutic Target?
Current Drug Targets Target-oriented Mechanisms of Novel Herbal Therapeutics in the Chemotherapy of Gastrointestinal Cancer and Inflammation
Current Pharmaceutical Design Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimers Disease
Current Alzheimer Research Disease Modifying Drugs in Multiple Sclerosis: Mechanisms of Action and New Drugs in the Horizon
CNS & Neurological Disorders - Drug Targets Recent Patents on Nucleic Acid-Based Antiviral Therapeutics
Recent Patents on Anti-Infective Drug Discovery Ewing Sarcoma Family Tumors: Past, Present and Future Prospects
Current Cancer Therapy Reviews Impact of the CD40-CD40L Dyad in Alzheimers Disease
CNS & Neurological Disorders - Drug Targets Activation of Latent HIV-1 Expression by Protein Kinase C Agonists. A Novel Therapeutic Approach to Eradicate HIV-1 Reservoirs
Current Drug Targets From Surface to Nuclear Receptors: The Endocannabinoid Family Extends its Assets
Current Medicinal Chemistry SARS-CoV-2 Encephalitis <i>versus</i> Influenza Encephalitis: More Similarities than Differences
Current Pediatric Reviews Dabigatran Reversal with Idarucizumab in an Emergency Lumbar Puncture: A Case Report
Current Drug Safety Protein Conformational Diseases: From Mechanisms to Drug Designs
Current Drug Discovery Technologies Gene Transfer to the Central Nervous System: Current State of the Art of the Viral Vectors
Current Genomics Targeted Blood-to-Brain Drug Delivery – 10 Key Development Criteria
Current Pharmaceutical Biotechnology Research Progress of Nanocarriers for the Treatment of Alzheimer's Disease
Current Pharmaceutical Design Immunobiology of Herpes Simplex Virus and Cytomegalovirus Infections of the Fetus and Newborn
Current Immunology Reviews (Discontinued)